153 related articles for article (PubMed ID: 8174087)
1. Detection of minimal residual disease after sex-mismatch bone marrow transplantation in chronic myelogenous leukemia by fluorescence in situ hybridization.
Nagler A; Slavin S; Yarkoni S; Fejgin M; Amiel A
Cancer Genet Cytogenet; 1994 Apr; 73(2):130-3. PubMed ID: 8174087
[TBL] [Abstract][Full Text] [Related]
2. Detection of minimal residual disease state in chronic myelogenous leukemia patients using fluorescence in situ hybridization.
Amiel A; Yarkoni S; Slavin S; Or R; Lorberboum-Galski H; Fejgin M; Nagler A
Cancer Genet Cytogenet; 1994 Aug; 76(1):59-64. PubMed ID: 8076354
[TBL] [Abstract][Full Text] [Related]
3. [Monitoring of bcr/abl fusion gene by interphase-dual-color and dual-fusion fluorescence in situ hybridization in CML after allo-HSCT].
Qian SX; Li JY; Zhang R; Hong M; Qiu HR; Li L; Xu W; Sheng RL; Wu HX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):577-81. PubMed ID: 16800946
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence in situ hybridization: a highly efficient technique of molecular diagnosis and predication for disease course in patients with myeloid leukemias.
Amare PS; Baisane C; Saikia T; Nair R; Gawade H; Advani S
Cancer Genet Cytogenet; 2001 Dec; 131(2):125-34. PubMed ID: 11750052
[TBL] [Abstract][Full Text] [Related]
5. Philadelphia chromosome in chronic myelogenous leukemia: confirmation of cytogenetic diagnosis in Ph positive and negative cases by fluorescence in situ hybridization.
Acar H; Stewart J; Connor MJ
Cancer Genet Cytogenet; 1997 Apr; 94(2):75-8. PubMed ID: 9109930
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of dual color-dual fusion translocation fluorescence in situ hybridization in the detection of bcr/abl fusion gene.
Wu B; Zhou S; Song L; Liu X
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):364-6. PubMed ID: 12408765
[TBL] [Abstract][Full Text] [Related]
7. Fluorescent in-situ hybridization (FISH) for BCR/ABL in chronic myeloid leukemia after bone marrow transplantation.
Chauffaille Mde L; Oliveira JS; Romeo M; Kerbauy J
Sao Paulo Med J; 2001 Jan; 119(1):16-8. PubMed ID: 11175620
[TBL] [Abstract][Full Text] [Related]
8. The ABL/BCR fusion gene on chromosome 9 in Ph-negative chronic myelogenous leukemia: a case for vigilance in fluorescence in situ hybridization interpretation.
Hsu WT; Preisler H; Szego K; Sprudzs R; Gao XZ
Cancer Genet Cytogenet; 1998 Jul; 104(1):57-60. PubMed ID: 9648560
[TBL] [Abstract][Full Text] [Related]
9. Detection of the Mbcr/abl translocation in chronic myeloid leukemia by fluorescence in situ hybridization: comparison with conventional cytogenetics and implications for minimal residual disease detection.
Garcia-Isidoro M; Tabernero MD; Garcia JL; Najera ML; Hernandez JM; Wiegant J; Raap A; San Miguel J; Orfao A
Hum Pathol; 1997 Feb; 28(2):154-9. PubMed ID: 9023395
[TBL] [Abstract][Full Text] [Related]
10. [The application of fluorescence in situ hybridization in detecting chronic myeloid leukemia].
Qiu HR; Miao KR; Wang R; Qiao C; Zhang JF; Zhang SJ; Qian SX; Xu W; Li JY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):207-10. PubMed ID: 19350518
[TBL] [Abstract][Full Text] [Related]
11. Detection and quantification of leukemia-specific rearrangements.
Hochhaus A
Methods Mol Med; 2002; 68():67-96. PubMed ID: 11901513
[No Abstract] [Full Text] [Related]
12. Application of fluorescence in situ hybridization to detect residual leukemic cells with 9;22 and 15;17 translocations.
Tanaka K; Arif M; Eguchi M; Kumaravel TS; Ueda R; Ohno R; Iwato K; Kyo T; Dohy H; Kamada N
Leukemia; 1997 Mar; 11(3):436-40. PubMed ID: 9067586
[TBL] [Abstract][Full Text] [Related]
13. [Detection of bcr/abl fusion gene and its derivative chromosome 9 deletions in CML by using home-made bcr/abl extra-signal probe].
Lai YY; Feng L; Wang Z; Lü S; Dang H; Shi Y; He Q; Huang XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):199-203. PubMed ID: 20137147
[TBL] [Abstract][Full Text] [Related]
14. Detection of the BCR-ABL gene by interphase fluorescence in situ hybridization (iFISH) in chronic myelogenous leukemia patients after hemopoietic stem cell transplantation: the feasibility of iFISH monitoring of therapeutic response in peripheral blood.
Lee YK; Lee DW; Kim YL; Lee S; Min CK; Kim YJ; Oh IH; Kim TG; Kim CC; Kim DW
Int J Hematol; 2002 Aug; 76(2):180-5. PubMed ID: 12215018
[TBL] [Abstract][Full Text] [Related]
15. [Detection of the BCR-ABL fusion: Comparative analysis of six commercially available FISH fusion probes].
Knas T; Buck M; Stegelmann F; Möller P; Barth TF
Pathologe; 2015 Jul; 36(4):372-84. PubMed ID: 26175197
[TBL] [Abstract][Full Text] [Related]
16. [Detection of Bcr/Abl gene rearrangement in chronic myelogenous leukemia patients by dual-color dual-fusion fluorescence in situ hybridization].
Guo B; Zhu HL; Li SX; Lu XC; Fan H; Zhao DD; Han XP; DA WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):261-5. PubMed ID: 19379547
[TBL] [Abstract][Full Text] [Related]
17. Detection of the Philadelphia chromosome in paraffin-embedded tissue by fluorescence in situ hybridization.
Brynes RK; McCourty A; Ho JP; Traweek ST; Snyder DS; Slovak ML
Mod Pathol; 1994 Jun; 7(5):565-9. PubMed ID: 7937723
[TBL] [Abstract][Full Text] [Related]
18. Conventional cytogenetics and FISH in the detection of BCR/ABL fusion in chronic myeloid leukemia (CML).
Mark HF; Sokolic RA; Mark Y
Exp Mol Pathol; 2006 Aug; 81(1):1-7. PubMed ID: 16729999
[No Abstract] [Full Text] [Related]
19. Improved sensitivity of BCR-ABL detection: a triple-probe three-color fluorescence in situ hybridization system.
Sinclair PB; Green AR; Grace C; Nacheva EP
Blood; 1997 Aug; 90(4):1395-402. PubMed ID: 9269756
[TBL] [Abstract][Full Text] [Related]
20. [Application of fluorescence in situ hybridization technique in diagnosis of variant Ph chromosome translocation and Ph-negative chronic myelocytic leukemia].
Jing Y; Jiang F; Lin S; Wang FT; Fang MY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Oct; 27(5):563-6. PubMed ID: 20931538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
